In the past 10 years, 14 companies have unsuccessfully attempted to secure FDA approval for an ocular surface drug. Interestingly, many of these drugs have been approved for use in Asia and/or Europe and have been commercially successful.Click here to read more about why dry eye trials often fail:
OUR COACHES
